At Phenaros, we begin where complexity usually ends - capturing the full spectrum of cellular morphology and using it as the foundation for AI-driven discovery. Our phenomics platform transforms high-content cell imaging into high-value insight, combining automation, scale, and precision to unlock answers others can’t see.
From the first experiment to the final prediction, every step is shaped by AI - designed to learn faster, test smarter, and bridge the gap between complex biology and actionable solutions. We unravel mechanisms of action, predict toxicity, screen compounds, and uncover opportunities with a confidence built on data quality, volume, and relevance.
Now, we stand at the edge of something greater. The science is strong, the vision is sharper, and the path ahead is opening into new territory. The pieces are coming together. The shape is becoming clear. Change is in the air… and the next chapter is about to begin. Cell by cell, pixel by pixel
Company Details
- Employees
- 12
- Founded
- -
- Address
- Uppsala, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.phenaros.com
- Keywords
- Drug Discovery, Compound profiling, Morphological profiling, Cell Painting, Phenotypic screening, AI, Automation, Large scale data.
- HQ
- Uppsala
Phenaros Questions
Phenaros's website is http://www.phenaros.com
Phenaros's LinkedIn profile is https://se.linkedin.com/company/phenaros
Phenaros has
12 employees.
View email and phone details for 12
employees at Phenaros.
Phenaros's industry is
Biotechnology Research
Phenaros's top competitors are
Mycural Therapeutics,
Biocell Analytica,
Dicot Pharma Ab,
Arguseye,
Probingon Ab,
Strike Pharma Ab,
Akiram Therapeutics,
Klaria Ab,
Rarity Bioscience,
Readily Diagnostics.
Phenaros's categories are Biotechnology Research
Phenaros's founding year is 2022
